Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California. Show more

3525 Del Mar Heights Rd., San Diego, CA, 92130, United States

Biotechnology

Healthcare

Market Cap

7.036M

52 Wk Range

$0.95 - $6.22

Previous Close

$1.38

Open

$1.38

Volume

230,392

Day Range

$1.36 - $1.47

Enterprise Value

2.425M

Cash

6.945M

Avg Qtr Burn

-2.48M

Insider Ownership

27.35%

Institutional Own.

7.77%

Qtr Updated

03/31/26

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Tome Foundational Treatment (Bioneedle Skin Renewal) Details Skin Renewal	Approved Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
XYNGARI™ (formerly DMT310) Details Moderate-to-severe acne	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
XYNGARI™ (formerly DMT310) Details Psoriasis	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
XYNGARI™ (formerly DMT310) Details Papulopustular rosacea	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Xyngari + Daxxify Details Primary axillary hyperhidrosis	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.